tiprankstipranks
Trending News
More News >
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market

Janux Therapeutics Inc (JANX) Stock Forecast & Price Target

Compare
710 Followers
See the Price Targets and Ratings of:

JANX Analyst Ratings

Strong Buy
17Ratings
Strong Buy
16 Buy
1 Hold
0 Sell
Based on 17 analysts giving stock ratings to
Janux
Therapeutics Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

JANX Stock 12 Month Forecast

Average Price Target

$49.14
▲(256.11% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Janux Therapeutics Inc in the last 3 months. The average price target is $49.14 with a high forecast of $100.00 and a low forecast of $12.00. The average price target represents a 256.11% change from the last price of $13.80.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","56":"$56","101":"$101","33.5":"$33.5","78.5":"$78.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$100.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49.14285714285714,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$49.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,33.5,56,78.5,101],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.99,20.606153846153845,27.222307692307695,33.83846153846154,40.45461538461539,47.07076923076924,53.68692307692308,60.30307692307692,66.91923076923077,73.53538461538461,80.15153846153846,86.7676923076923,93.38384615384615,{"y":100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.99,16.694065934065932,19.398131868131866,22.1021978021978,24.806263736263734,27.510329670329668,30.214395604395598,32.918461538461536,35.622527472527466,38.3265934065934,41.030659340659334,43.73472527472527,46.4387912087912,{"y":49.14285714285714,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.99,13.836923076923076,13.683846153846154,13.53076923076923,13.377692307692309,13.224615384615385,13.071538461538461,12.918461538461539,12.765384615384615,12.612307692307692,12.45923076923077,12.306153846153846,12.153076923076924,{"y":12,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":43.48,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.89,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.81,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.01,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.22,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.56,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.86,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.71,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.99,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.99,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$100.00Average Price Target$49.14Lowest Price Target$12.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
LifeSci Capital Analyst forecast on JANX
LifeSci Capital
LifeSci Capital
$60
Buy
334.78%
Upside
Reiterated
02/27/26
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
Barclays Analyst forecast on JANX
Barclays
Barclays
$29
Buy
110.14%
Upside
Reiterated
02/27/26
Barclays Sticks to Their Buy Rating for Janux Therapeutics Inc (JANX)
Piper Sandler Analyst forecast on JANX
Piper Sandler
Piper Sandler
$30
Buy
117.39%
Upside
Reiterated
02/27/26
Piper Sandler Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)
William Blair Analyst forecast on JANX
William Blair
William Blair
Buy
Reiterated
02/27/26
Janux Therapeutics: Rebuilding Confidence After JANX007 Setback with 2026 Clinical Catalysts and Validated PSMA x CD3 Platform
Bank of America Securities Analyst forecast on JANX
Bank of America Securities
Bank of America Securities
$35$29
Buy
110.14%
Upside
Reiterated
02/27/26
Janux Therapeutics Inc (JANX) Gets a Buy from Bank of America Securities
TD Cowen Analyst forecast on JANX
TD Cowen
TD Cowen
Buy
Reiterated
02/26/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX) and Syndax Pharmaceuticals (NASDAQ: SNDX)
Cantor Fitzgerald Analyst forecast on JANX
Cantor Fitzgerald
Cantor Fitzgerald
$150$100
Buy
624.64%
Upside
Reiterated
02/26/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX), Progyny (NASDAQ: PGNY) and Concentra Group Holdings Parent, Inc. (NYSE: CON)
Guggenheim Analyst forecast on JANX
Guggenheim
Guggenheim
$72$68
Buy
392.75%
Upside
Reiterated
02/26/26
Janux Therapeutics price target lowered to $68 from $72 at GuggenheimJanux Therapeutics price target lowered to $68 from $72 at Guggenheim
Wedbush Analyst forecast on JANX
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$45
Buy
226.09%
Upside
Reiterated
02/24/26
Janux Therapeutics Inc (JANX) Receives a Buy from Wedbush
Truist Financial Analyst forecast on JANX
Truist Financial
Truist Financial
Buy
Reiterated
02/24/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Janux Therapeutics Inc (NASDAQ: JANX) and CVS Health (NYSE: CVS)
H.C. Wainwright Analyst forecast on JANX
H.C. Wainwright
H.C. Wainwright
$45
Buy
226.09%
Upside
Reiterated
02/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Masimo (NASDAQ: MASI), Janux Therapeutics Inc (NASDAQ: JANX) and Beta Bionics, Inc. (NASDAQ: BBNX)
JonesTrading Analyst forecast on JANX
JonesTrading
JonesTrading
$50
Buy
262.32%
Upside
Assigned
01/23/26
Janux Therapeutics Inc (JANX) Gets a Buy from JonesTrading
BTIG
$100
Buy
624.64%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT) and Janux Therapeutics Inc (NASDAQ: JANX)
Clear Street Analyst forecast on JANX
Clear Street
Clear Street
$32$12
Hold
-13.04%
Downside
Downgraded
01/20/26
Janux Therapeutics downgraded to Hold from Buy at Clear StreetJanux Therapeutics downgraded to Hold from Buy at Clear Street
Stifel Nicolaus Analyst forecast on JANX
Stifel Nicolaus
Stifel Nicolaus
$46$38
Buy
175.36%
Upside
Reiterated
12/02/25
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
LifeSci Capital Analyst forecast on JANX
LifeSci Capital
LifeSci Capital
$60
Buy
334.78%
Upside
Reiterated
02/27/26
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
Barclays Analyst forecast on JANX
Barclays
Barclays
$29
Buy
110.14%
Upside
Reiterated
02/27/26
Barclays Sticks to Their Buy Rating for Janux Therapeutics Inc (JANX)
Piper Sandler Analyst forecast on JANX
Piper Sandler
Piper Sandler
$30
Buy
117.39%
Upside
Reiterated
02/27/26
Piper Sandler Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)
William Blair Analyst forecast on JANX
William Blair
William Blair
Buy
Reiterated
02/27/26
Janux Therapeutics: Rebuilding Confidence After JANX007 Setback with 2026 Clinical Catalysts and Validated PSMA x CD3 Platform
Bank of America Securities Analyst forecast on JANX
Bank of America Securities
Bank of America Securities
$35$29
Buy
110.14%
Upside
Reiterated
02/27/26
Janux Therapeutics Inc (JANX) Gets a Buy from Bank of America Securities
TD Cowen Analyst forecast on JANX
TD Cowen
TD Cowen
Buy
Reiterated
02/26/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX) and Syndax Pharmaceuticals (NASDAQ: SNDX)
Cantor Fitzgerald Analyst forecast on JANX
Cantor Fitzgerald
Cantor Fitzgerald
$150$100
Buy
624.64%
Upside
Reiterated
02/26/26
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX), Progyny (NASDAQ: PGNY) and Concentra Group Holdings Parent, Inc. (NYSE: CON)
Guggenheim Analyst forecast on JANX
Guggenheim
Guggenheim
$72$68
Buy
392.75%
Upside
Reiterated
02/26/26
Janux Therapeutics price target lowered to $68 from $72 at GuggenheimJanux Therapeutics price target lowered to $68 from $72 at Guggenheim
Wedbush Analyst forecast on JANX
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$45
Buy
226.09%
Upside
Reiterated
02/24/26
Janux Therapeutics Inc (JANX) Receives a Buy from Wedbush
Truist Financial Analyst forecast on JANX
Truist Financial
Truist Financial
Buy
Reiterated
02/24/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Janux Therapeutics Inc (NASDAQ: JANX) and CVS Health (NYSE: CVS)
H.C. Wainwright Analyst forecast on JANX
H.C. Wainwright
H.C. Wainwright
$45
Buy
226.09%
Upside
Reiterated
02/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Masimo (NASDAQ: MASI), Janux Therapeutics Inc (NASDAQ: JANX) and Beta Bionics, Inc. (NASDAQ: BBNX)
JonesTrading Analyst forecast on JANX
JonesTrading
JonesTrading
$50
Buy
262.32%
Upside
Assigned
01/23/26
Janux Therapeutics Inc (JANX) Gets a Buy from JonesTrading
BTIG
$100
Buy
624.64%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT) and Janux Therapeutics Inc (NASDAQ: JANX)
Clear Street Analyst forecast on JANX
Clear Street
Clear Street
$32$12
Hold
-13.04%
Downside
Downgraded
01/20/26
Janux Therapeutics downgraded to Hold from Buy at Clear StreetJanux Therapeutics downgraded to Hold from Buy at Clear Street
Stifel Nicolaus Analyst forecast on JANX
Stifel Nicolaus
Stifel Nicolaus
$46$38
Buy
175.36%
Upside
Reiterated
12/02/25
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Janux Therapeutics Inc

3 Months
xxx
Success Rate
5/11 ratings generated profit
45%
Average Return
+6.85%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of +6.85% per trade.
1 Year
Swayampakula RamakanthH.C. Wainwright
Success Rate
4/16 ratings generated profit
25%
Average Return
+32.71%
a rating ―
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of +32.71% per trade.
2 Years
xxx
Success Rate
4/16 ratings generated profit
25%
Average Return
-13.52%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -13.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

JANX Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
19
21
25
27
24
Buy
4
4
11
10
12
Hold
0
1
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
26
37
39
37
In the current month, JANX has received 36 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. JANX average Analyst price target in the past 3 months is 49.14.
Each month's total comprises the sum of three months' worth of ratings.

JANX Financial Forecast

JANX Earnings Forecast

Next quarter’s earnings estimate for JANX is -$0.61 with a range of -$0.93 to -$0.41. The previous quarter’s EPS was -$0.51. JANX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.
Next quarter’s earnings estimate for JANX is -$0.61 with a range of -$0.93 to -$0.41. The previous quarter’s EPS was -$0.51. JANX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.

JANX Sales Forecast

Next quarter’s sales forecast for JANX is $1.96M with a range of $0.00 to $15.00M. The previous quarter’s sales results were ―. JANX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.
Next quarter’s sales forecast for JANX is $1.96M with a range of $0.00 to $15.00M. The previous quarter’s sales results were ―. JANX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year JANX has Performed in-line its overall industry.

JANX Stock Forecast FAQ

What is JANX’s average 12-month price target, according to analysts?
Based on analyst ratings, Janux Therapeutics Inc’s 12-month average price target is 49.14.
    What is JANX’s upside potential, based on the analysts’ average price target?
    Janux Therapeutics Inc has 256.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is JANX a Buy, Sell or Hold?
          Janux Therapeutics Inc has a consensus rating of Strong Buy which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Janux Therapeutics Inc’s price target?
            The average price target for Janux Therapeutics Inc is 49.14. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $100.00 ,the lowest forecast is $12.00. The average price target represents 256.11% Increase from the current price of $13.8.
              What do analysts say about Janux Therapeutics Inc?
              Janux Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of JANX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.